South Africa's drug industry trade association has relaunched itself with a new name and assembling about 55% of the country's drugmakers by value. The Pharmaceutical Industry Association of South Africa replaces the older Pharmaceutical Manufacturers Association, which represented foreign branded drugmakers, and includes local generic drug firms.
One of the driving forces in bringing together research-based and generic drugmakers has been the South African government's price control system that proposes an automatic 40% discount for generics versus branded products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze